Tamihardja, J.; Zehner, L.; Hartrampf, P.; Lisowski, D.; Kneitz, S.; Cirsi, S.; Razinskas, G.; Flentje, M.; Polat, B.
Salvage Nodal Radiotherapy as Metastasis-Directed Therapy for Oligorecurrent Prostate Cancer Detected by Positron Emission Tomography Shows Favorable Outcome in Long-Term Follow-Up. Cancers 2022, 14, 3766.
https://doi.org/10.3390/cancers14153766
AMA Style
Tamihardja J, Zehner L, Hartrampf P, Lisowski D, Kneitz S, Cirsi S, Razinskas G, Flentje M, Polat B.
Salvage Nodal Radiotherapy as Metastasis-Directed Therapy for Oligorecurrent Prostate Cancer Detected by Positron Emission Tomography Shows Favorable Outcome in Long-Term Follow-Up. Cancers. 2022; 14(15):3766.
https://doi.org/10.3390/cancers14153766
Chicago/Turabian Style
Tamihardja, Jörg, Leonie Zehner, Philipp Hartrampf, Dominik Lisowski, Susanne Kneitz, Sinan Cirsi, Gary Razinskas, Michael Flentje, and Bülent Polat.
2022. "Salvage Nodal Radiotherapy as Metastasis-Directed Therapy for Oligorecurrent Prostate Cancer Detected by Positron Emission Tomography Shows Favorable Outcome in Long-Term Follow-Up" Cancers 14, no. 15: 3766.
https://doi.org/10.3390/cancers14153766
APA Style
Tamihardja, J., Zehner, L., Hartrampf, P., Lisowski, D., Kneitz, S., Cirsi, S., Razinskas, G., Flentje, M., & Polat, B.
(2022). Salvage Nodal Radiotherapy as Metastasis-Directed Therapy for Oligorecurrent Prostate Cancer Detected by Positron Emission Tomography Shows Favorable Outcome in Long-Term Follow-Up. Cancers, 14(15), 3766.
https://doi.org/10.3390/cancers14153766